RCUS
Arcus Biosciences, Inc. · Healthcare
CFO II Robert C. Goeltz sold $153K of Arcus Biosciences, Inc.
Sold$153,186
$23.38Price
6,552Shares
−9%Stake
What RCUS did after the filing
- The stock from Fri, Jan 2 close, $23.29
- −17.4%
- S&P 500, same days
- 0.0%
Measured over 30 trading days, to the Feb 17 close.
Traded Wed, Dec 31. Filed Fri, Jan 2, 11:19 AM ET, during the session. Returns use the Jan 2 close and the Feb 17 close. Not investment advice.